Skip to main content
Top
Published in: Diabetologia 2/2004

01-02-2004 | Short Communication

Effect of sodium intake on blood pressure and albuminuria in Type 2 diabetic patients: the role of insulin resistance

Authors: M. Vedovato, G. Lepore, A. Coracina, A. R. Dodesini, E. Jori, A. Tiengo, S. Del Prato, R. Trevisan, MD PhD

Published in: Diabetologia | Issue 2/2004

Login to get access

Abstract

Aims/hypothesis

This study was done to measure the effect of Na+ intake on blood pressure and albuminuria, in relation with insulin sensitivity and kidney haemodynamics, in Type 2 diabetic patients with and without microalbuminuria.

Methods

Type 2 diabetic patients, 20 with microalbuminuria, 21 without, spent two consecutive 7-day periods, one on a high (250 mmol), the other on a low-Na+ (20 mmol) diet. Body weight, 24-h blood pressure and albuminuria were measured at the end of each period. At the end of high-Na+ diet insulin sensitivity (euglycaemic insulin clamp; 2 mU·kg−1·min−1) and kidney haemodynamics were measured in nine patients from each group.

Results

Switching from low to high-Na+ diet resulted in an increase in blood pressure (7.4±4.7 mmHg; p<0.001), body weight (1.9±0.4 kg; p<0.05) and albuminuria [from 80 (31–183) µg/min to 101 (27–965) µg/min; p<0.01) in patients with microalbuminuria. No changes occurred in patients without microalbuminuria. Patients with microalbuminuria also had greater intraglomerular pressure (44±1 mmHg vs 36±1; p<0.001), calculated from glomerular filtration rate, renal plasma flow, plasma protein concentration and the relationship between pressure and natriuresis. In these patients insulin sensitivity was lower (5.16±49 vs 7.36±0.63 mg·kg−1·min−1; p=0.007). Urinary albumin excretion (r=0.40; p=0.009) and insulin sensitivity (r=−0.59; p=0.01) were correlated with intraglomerular pressure.

Conclusion/interpretation

High salt intake increases blood pressure and albuminuria in Type 2 diabetic patients with microalbuminuria. These responses are associated with insulin resistance and increased glomerular pressure. Insulin resistance could contribute to greater salt sensitivity, increased glomerular pressure and albuminuria.
Literature
1.
go back to reference Mogensen CE (1999) Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas. Diabetologia 42:263–285 Mogensen CE (1999) Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas. Diabetologia 42:263–285
2.
go back to reference Beretta-Piccoli C, Weidmann P (1982) Body sodium-volume state in nonazotemic diabetes mellitus. Miner Electrolyte Metab 7:36–47PubMed Beretta-Piccoli C, Weidmann P (1982) Body sodium-volume state in nonazotemic diabetes mellitus. Miner Electrolyte Metab 7:36–47PubMed
3.
go back to reference Imanishi M, Yoshioka K, Okumura M et al. (2001) Sodium sensitivity related to albuminuria appearing before hypertension in Type 2 diabetic patients. Diabetes Care 24:111–116 Imanishi M, Yoshioka K, Okumura M et al. (2001) Sodium sensitivity related to albuminuria appearing before hypertension in Type 2 diabetic patients. Diabetes Care 24:111–116
4.
go back to reference Trevisan R, Bruttomesso D, Vedovato M et al. (1998) Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria. Diabetes 47:1347–1353 Trevisan R, Bruttomesso D, Vedovato M et al. (1998) Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria. Diabetes 47:1347–1353
5.
go back to reference Imanishi M, Yoshioka K, Konishi Y et al. (1999) Glomerular hypertension as one cause of albuminuria in type II diabetic patients. Diabetologia 42:999–1005 Imanishi M, Yoshioka K, Konishi Y et al. (1999) Glomerular hypertension as one cause of albuminuria in type II diabetic patients. Diabetologia 42:999–1005
6.
go back to reference De’Oliveira JM, Price DA, Fisher ND et al. (1997) Autonomy of the renin system in Type II diabetes mellitus: dietary sodium and renal hemodynamic responses to ACE inhibition. Kidney Int 52:771–777PubMed De’Oliveira JM, Price DA, Fisher ND et al. (1997) Autonomy of the renin system in Type II diabetes mellitus: dietary sodium and renal hemodynamic responses to ACE inhibition. Kidney Int 52:771–777PubMed
7.
go back to reference Bianchi S, Bigazzi R, Quinones Galvan A et al. (1995) Insulin resistance in microalbuminuric hypertension. Sites and mechanisms. Hypertension 26:789–795PubMed Bianchi S, Bigazzi R, Quinones Galvan A et al. (1995) Insulin resistance in microalbuminuric hypertension. Sites and mechanisms. Hypertension 26:789–795PubMed
8.
go back to reference Trevisan R, Fioretto P, Semplicini A et al. (1990) Role of insulin and atrial natriuretic peptide in sodium retention in insulin-treated IDDM patients during isotonic volume expansion. Diabetes 39:289–298 Trevisan R, Fioretto P, Semplicini A et al. (1990) Role of insulin and atrial natriuretic peptide in sodium retention in insulin-treated IDDM patients during isotonic volume expansion. Diabetes 39:289–298
9.
go back to reference Houlihan CA, Allen TJ, Baxter AL et al. (2002) A low-sodium diet potentiates the effects of losartan in type 2 diabetes. Diabetes Care 25:663–671 Houlihan CA, Allen TJ, Baxter AL et al. (2002) A low-sodium diet potentiates the effects of losartan in type 2 diabetes. Diabetes Care 25:663–671
10.
go back to reference Mogensen CE, Viberti G, Halimi S et al. (2003) Effect of low-dose perindopril/indapamide on albuminuria in diabetes. Preterax in Albuminuria Regression (PREMIER) Study Group. Hypertension 41:1063–1071CrossRefPubMed Mogensen CE, Viberti G, Halimi S et al. (2003) Effect of low-dose perindopril/indapamide on albuminuria in diabetes. Preterax in Albuminuria Regression (PREMIER) Study Group. Hypertension 41:1063–1071CrossRefPubMed
Metadata
Title
Effect of sodium intake on blood pressure and albuminuria in Type 2 diabetic patients: the role of insulin resistance
Authors
M. Vedovato
G. Lepore
A. Coracina
A. R. Dodesini
E. Jori
A. Tiengo
S. Del Prato
R. Trevisan, MD PhD
Publication date
01-02-2004
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 2/2004
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-003-1303-5

Other articles of this Issue 2/2004

Diabetologia 2/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine